The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety

PARP inhibitors: A new era of targeted therapy

(2015) Shifalika Tangutoori et al.   MATURITAS

Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer

(2014) I. A. P. Derks-Smeets et al.   HUMAN REPRODUCTION

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

(2013) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

An audit of clinical service examining the uptake of genetic testing by at-risk family members

(2012) Laura Forrest et al.   GENETICS IN MEDICINE

A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives

(2010) Joël Vos et al.   Familial Cancer

Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives

(2009) DGR Evans et al.   CLINICAL GENETICS

Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome

(2008) Larissa I Batista et al.   BMC CANCER